Skip to content

To check the difference in participants who undergo laser any dermatology procedure before and after surgery with the effect of plant extracted spray.

Prospective Observational study of Mimosa teniflora based Cicaderm spray for dermatology surgeries as post-operative care- A cross sectional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076592
Enrollment
300
Registered
2024-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

DrMerin Dickson Mickhayel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged more than 18 years 2. Patients who have successfully completed the informed consent process prior to their participation. 3. Patients who are willing to provide the clinical pictures (Pre -operative and postoperative) 4. Patients who are willing to use the Cicaderm spray for 7-14 days as per the physician’s prescription.

Exclusion criteria

Exclusion criteria: Patients who are unwilling to provide the consent Patients who are undergoing any cancer treatment

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Cicaderm extract spray after dermatological procedures as post procedure skin care. Timepoint: Baseline visit 0-7 days : Data Collection Efficacy and safety will be analysed in Follow up visits time line :7-14 days

Secondary

MeasureTime frame
To assess the safety of Cicaderm spray Evaluate the cosmetic qualities and the perception of effectivenessTimepoint: Day 1 to 14 days

Countries

India

Contacts

Public ContactDr Merin Dickson

Docmode Health

dr.merin@docmode.com9130224455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026